Matthew O’Sullivan
Impact in
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 25
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 5
-
- Bacterial Identification and Susceptibility Testing 18
- Co-authors
- Gwendolyn L. Gilbert (20 shared papers)Benjamin P. Howden (7 shared papers)James O. Robinson (8 shared papers)Vitali Sintchenko (19 shared papers)Sally Roberts (4 shared papers)Paul D. R. Johnson (4 shared papers)Fanrong Kong (8 shared papers)Tony M. Korman (4 shared papers)
- Journals
- Journal of Clinical Microbiology (9 papers)Pathology (4 papers)Clinical Infectious Diseases (4 papers)Trials (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- AustraliaChinaUnited Kingdom
In The Last Decade
Matthew O’Sullivan
67 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.0k
- Clinical Biochemistry 380
- Molecular Medicine 98
- Applied Microbiology and Biotechnology 32
- Microbiology 57
Countries citing papers authored by Matthew O’Sullivan
This map shows the geographic impact of Matthew O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew O’Sullivan more than expected).
Fields of papers citing papers by Matthew O’Sullivan
This network shows the impact of papers produced by Matthew O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew O’Sullivan. The network helps show where Matthew O’Sullivan may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew O’Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 176 | |
| 2 | 2013 | 163 | |
| 3 | 2015 | 141 | |
| 4 | 2005 | 85 | |
| 5 | 1979 | 77 | |
| 6 | 2020 | 75 | |
| 7 | 2020 | 67 | |
| 8 | 2013 | 66 | |
| 9 | 2016 | 54 | |
| 10 | 2015 | 46 | |
| 11 | 2006 | 42 | |
| 12 | 2015 | 38 | |
| 13 | 2012 | 33 | |
| 14 | 2020 | 31 | |
| 15 | 2022 | 31 | |
| 16 | 2016 | 31 | |
| 17 | 2014 | 30 | |
| 18 | 2016 | 30 | |
| 19 | 2015 | 29 | |
| 20 | 2017 | 28 |
About Matthew O’Sullivan
Matthew O’Sullivan is a scholar working on Infectious Diseases, Clinical Biochemistry, Molecular Biology, Epidemiology and Ecology, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (25 papers), Bacterial Identification and Susceptibility Testing (18 papers), Bacterial biofilms and quorum sensing (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers), Bacteriophages and microbial interactions (5 papers), Bacillus and Francisella bacterial research (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Clinical Biochemistry (380 citations), Molecular Medicine (98 citations), Applied Microbiology and Biotechnology (32 citations) and Microbiology (57 citations). Matthew O’Sullivan has collaborated with scholars based in Australia, China and United Kingdom. Frequent co-authors include Gwendolyn L. Gilbert, Benjamin P. Howden, James O. Robinson, Vitali Sintchenko, Sally Roberts, Paul D. R. Johnson, Fanrong Kong, Tony M. Korman, John Turnidge and Wei Gao. Their work appears in journals such as Journal of Clinical Microbiology, Pathology, Clinical Infectious Diseases, Trials and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.